logo
Plus   Neg
Share
Email

Roche: EU Approves Kadcyla For Adjuvant Treatment In HER2-positive Breast Cancer

Swiss drug maker Roche Group (RHHBY) announced Thursday that the European Commission has approved Kadcyla (trastuzumab emtansine) for the adjuvant (after surgery) treatment of people with HER2-positive early breast cancer with residual invasive disease after neoadjuvant (before surgery)treatment.

The approval was based on the phase III KATHERINE trial data showing Kadcyla significantly reduced the risk of invasive breast cancer recurrence or death by half compared to Herceptin (trastuzumab) as an adjuvant treatment.

Kadcyla is approved in Europe for the adjuvant treatment of adult patients with HER2-positive early breast cancer or eBC who have residual invasive disease in the breast and/or lymph nodes after neoadjuvant taxane-based and HER2-targeted therapy.

The goal of neoadjuvant treatment is to shrink tumours in order to help improve surgical outcomes. Adjuvant treatment aims to eliminate any remaining cancer cells in the body to help reduce the risk of the cancer returning. People who have residual disease after neoadjuvant treatment have a worse prognosis than those with no detectable disease.

Levi Garraway, Roche's Chief Medical Officer and Head of Global Product Development, said, "This approval of Kadcyla will allow many more women with HER2-positive early breast cancer to be given a transformative treatment that may cut the risk of their disease returning or progressing."

In the US, the Food and Drug Administration approved the adjuvant treatment with Kadcyla in May, following which thousands of women are already being given this treatment.

Kadcyla in this setting is now approved in 27 countries worldwide and the use of Kadcyla in eBC has been recommended by multiple treatment guidelines.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
In view of an expected growth in online shopping in the upcoming holiday season, Walmart announced its plan to hire more than 20,000 seasonal associates in its eCommerce fulfillment centers across the country. The company offers a starting hourly rate ranging from $15.75 up to $23.75 based on location, position and schedule. Tour operator TUI AG Tuesday said Summer 2020 and Winter 2020/21 capacity reduced as a result of recent volatile changes in travel restrictions amid Covid-19 pandemic. The company further announced the launch of Global Realignment Programme, aiming to permanently reduce overhead cost base by 30%. The program potentially impacts 8,000 roles. Home improvement retailer Lowe's Companies Inc. plans to install pickup lockers at all U.S. stores aiming to improve contactless delivery for online buyers amid worsening Covid-19 spread. The "Buy Online Pickup in Store" self-service lockers at its more than 1,700 stores will be available by the end of March 2021. In most major metro markets, the online pickup option will be installed by Thanksgiv
Follow RTT